Concepedia

Carol Waghorne

CW

20

Publications

2.4K

Citations

16

H-Index

1978

Active since

Affiliations

Harvard University(Current)

University of Toronto

Boston Children's Hospital

Dalhousie University

Mount Sinai Hospital

Carol Waghorne is an author at Harvard University specializing in medicine, tumor biology, and cell biology.

Top concepts

Publications per year

1978–2012

20

Publications

20

β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis

James W. Dennis, Suzanne Laferté, Carol Waghorne et al. · Science · 1987 · 937 citations

Phase I Trial of a Selective c-MET Inhibitor ARQ 197 Incorporating Proof of Mechanism Pharmacodynamic Studies

Timothy A. Yap, David Olmos, André T. Brunetto et al. · Journal of Clinical Oncology · 2011 · 193 citations · Full text

Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor–associated tumors

Andrew J. Wagner, John M. Goldberg, Steven G. DuBois et al. · Cancer · 2012 · 154 citations

Cytoskeletal stiffness, friction, and fluidity of cancer cell lines with different metastatic potential

Mark F. Coughlin, Diane R. Bielenberg, Guillaume Lenormand et al. · Clinical & Experimental Metastasis · 2012 · 125 citations · Full text

, , +14

Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Robert S. Kerbel, Carol Waghorne, Mi Man et al. · Proceedings of the National Academy of Sciences · 1987 · 119 citations · Full text

, , +15

Rows per page

1–5 of 20